willermain Profile Banner
Fabian Willermain Profile
Fabian Willermain

@willermain

Followers
638
Following
4K
Media
56
Statuses
3K

EU Institutional Affairs & Strategic Partnerships | views my own. RT≠endorsement.

Bruxelles, Belgique
Joined August 2014
Don't wanna be here? Send us removal request.
@lesoir
Le Soir
7 months
Incendie en cours à Bruxelles : les riverains invités à garder portes et fenêtres fermées (photos)
Tweet card summary image
lesoir.be
Un incendie s’est déclenché à Koekelberg ce mardi matin. Il est désormais maîtrisé.
0
3
1
@AlbertBourla
Albert Bourla
2 years
We shared @Pfizer’s 2024 Q1 results today. We had a solid start to the year, and I’m proud that in the first three months, we reached more than 119M patients* with our medicines and vaccines. Additionally, we have made notable progress on our five strategic priorities, from
0
7
42
@EFPIA
EFPIA
2 years
Europe is the slowest region to approve new medicines. With the revision of the #EUPharmaLegislation, policymakers have an opportunity to ensure Europeans benefit from the latest advances in care, without compromising on quality and safety: https://t.co/0xnK4Hok3V #WeWontRest
0
6
15
@pfizer
Pfizer Inc.
2 years
2023 was a year of challenges and achievements. Our #AnnualReview spotlights the work we did this past year to improve global health and the people behind those efforts. Our CEO @AlbertBourla shares more. 👇
@AlbertBourla
Albert Bourla
2 years
In our newly published 2023 Pfizer Annual Review and 2023 Pfizer Impact Report, I have the honor of personally telling the story of @Pfizer colleagues’ accomplishments over the past year. Now, as we embark on our 175th year of advancing science for healthcare, I know that our
0
10
35
@EFPIA
EFPIA
2 years
Europe's #regulatory system can be a brake or an accelerator in bringing new treatments to patients. As #science evolves, it is vital that policymakers design rules with the flexibility that the future will demand. Read more: https://t.co/Mt961023Kr #WeWontRest #DIAEurope2024
0
3
3
@Reuters_Health
Reuters Health
2 years
Pfizer said on Tuesday a combination treatment using its drug, Adcetris, met the main goal of a late-stage study of extending survival in patients with a type of blood cancer. https://t.co/94UsB9wAkj
reuters.com
Pfizer said on Tuesday its drug, Adcetris, extended survival in patients with the most common type of lymphoma in a late-stage study, bolstering efforts to expand the use of the treatment gained...
0
3
2
@Reuters_Health
Reuters Health
3 years
Roche Holding has teamed up with Pfizer on a U.S. campaign to boost awareness of COVID-19 testing and treatment, the Swiss drugmaker said on Wednesday.
2
4
5
@pfizer
Pfizer Inc.
3 years
Today we announced a Phase 1 study with @BioNTech_Group of an #mRNA-based combination vaccine candidate for #influenza and #COVID19, aiming to help protect against both diseases at once. Learn more: https://t.co/6TOHyDCT0r
298
71
147
@Reuters_Health
Reuters Health
3 years
Pfizer Inc said on Thursday it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seeks to address worldwide disparities in COVID response.
reuters.com
Pfizer Inc said on Thursday it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seeks to address worldwide...
0
1
6
@AlbertBourla
Albert Bourla
4 years
This week a shipment of @Pfizer patented medicines & vaccines to treat & prevent life-threatening infectious diseases, inflammatory disease & certain cancers arrived in #Rwanda under An Accord for a Healthier World. We are working together to close the #healthequity gap!
@RwandaHealth
Ministry of Health | Rwanda
4 years
The Ministry of Health has received eight categories of Pfizer medicines and vaccines for infectious and inflammatory diseases and certain cancers through ‘An Accord for a Healthier World’ signed between the Government of Rwanda and @pfizer.
15
5
41
@IFPMA
IFPMA
4 years
With the Berlin Declaration, we presented our vision for equitable access in pandemics. But "industry cannot do it alone." We call on stakeholders to play their part in shaping a future where everyone is better protected from the threat of pandemics.⬇️ https://t.co/g8FLhKNF2z
0
5
5
@IFPMA
IFPMA
4 years
Today, the biopharmaceutical industry shares its proposal for a joint solution on more equitable access to vaccines, treatments & diagnostics in future pandemics. We call on @G7, @g20org & others to support our vision for better preparedness: https://t.co/D0mJbzn08B
2
28
41
@AmChamBE
AmCham Belgium
4 years
🇺🇸 @pfizer is one of the new investors in 🇧🇪 Ghent-based #biotech AgomAb Therapeutics, which is developing innovative treatments to repair tissue and organs damaged by #fibrosis. https://t.co/CkQ1FI8CHc via @tijd #Yes2Belgium #BeHealth
tijd.be
De Belgische biotechbelofte Agomab werkt aan medicijnen die ziektes niet enkel afremmen, maar ook schade aan longen of darmen herstellen. ‘Wat we doen, is echt baanbrekend’, klinkt het. De Amerikaa...
0
3
2
@kuiper_em
Elizabeth Kuiper
4 years
At our recent @epc_eu conference on 30 years of EU health competences @Campus_Brussels, we discussed the impact of health crises on health policy in the past three decades. Read here our takeaways, written by my team member @bradydanielle23: https://t.co/BckHWQyikZ
1
7
20
@pfizer
Pfizer Inc.
4 years
To help eliminate the leading infectious cause of blindness, today at the #KigaliSummit we extended our global trachoma antibiotic donation program with @ITIatlanta through 2030. Learn more about what this means for #GlobalHealth: https://t.co/ZXYoQD2cuU #BeatNTDs
7
9
31
@AlbertBourla
Albert Bourla
4 years
Today, I updated @Pfizer colleagues on our pledge to donate the equivalent of all profits from our sales in Russia to causes providing humanitarian support to the people of Ukraine. Proud to say we’re making good on this promise. View the message here:
17
16
69
@ebsummiteurope
European Business Summits
4 years
#HealthSummitEU2022 "HERA is a white page: we know what we want to do, but not how we want to achieve it. Everyone involved now will participate in the success or failure of HERA. And I'm optimistic about that." - Pierre Delsaux Director General, HERA, @EU_Health
0
1
2
@ebsummiteurope
European Business Summits
4 years
#HealthSummitEU2022 "We know that COVID-19 will not be the last pandemic threat we face, and we must act with the same urgency in preventing and preparing for the next pandemic as we have in fighting this one. " - @runnerosborn, Regional President @pfizer hospitals
0
1
0
@willermain
Fabian Willermain
4 years
#Pfizer Launches ‘An Accord for a Healthier World’ to Improve #Health Equity for 1.2 Billion People Living in 45 Lower-Income Countries #equitable #access #Pfizeproud #StrongerTogether
@pfizer
Pfizer Inc.
4 years
Today, we were joined by Rwanda, Ghana, Senegal, Malawi & Uganda as we launched a new initiative to help close the global health equity gap & enable sustained access to medicines and vaccines in 45 lower-income countries. More here: https://t.co/OuF96mN9l9 #HealthEquity #WEF22
1
0
0
@Reuters_Health
Reuters Health
4 years
Pfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday.
0
9
6